Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Med., 01 October 2025

Sec. Hepatobiliary Diseases

Volume 12 - 2025 | https://doi.org/10.3389/fmed.2025.1704750

Correction: Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies

This article is a correction to:

  1. Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies

    1. Read original article
Mohammad HabibullahMohammad Habibullah1Khaleed JemmiehKhaleed Jemmieh1Amr OudaAmr Ouda1Mohammad Zulqurnain HaiderMohammad Zulqurnain Haider1Mohammed Imad Malki Mohammed Imad Malki1*Abdel-Naser Elzouki,, Abdel-Naser Elzouki1,2,3*
  • 1College of Medicine, QU Health, Qatar University, Doha, Qatar
  • 2Internal Medicine Department, Hamad General Hospital, Doha, Qatar
  • 3Weill Cornell Medical Qatar, Doha, Qatar

A Correction on
Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies

by Habibullah, M., Jemmieh, K., Ouda, A., Haider, M. Z., Malki, M. I, and Elzouki, A.-N. (2024). Front. Med. 11:1291501. doi: 10.3389/fmed.2024.1291501

An incorrect Funding statement was provided. The correct funder is “Medical Research Center of Hamad Medical Corporation-Qatar.” The correct funding statement should read:

We would like to acknowledge Medical Research Center of Hamad Medical Corporation-Qatar for funding this article.

The original version of this article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: metabolic associated fatty liver disease (MAFLD), non-alcoholic fatty liver disease (NAFLD), diagnostic criteria, hepatic steatosis, nonalcoholic steatohepatitis (NASH), epidemiology, clinical manifestations, pathogenesis

Citation: Habibullah M, Jemmieh K, Ouda A, Haider MZ, Malki MI and Elzouki A-N (2025) Correction: Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies. Front. Med. 12:1704750. doi: 10.3389/fmed.2025.1704750

Received: 13 September 2025; Accepted: 15 September 2025;
Published: 01 October 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Habibullah, Jemmieh, Ouda, Haider, Malki and Elzouki. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Mohammed Imad Malki, bW9tYWxraUBxdS5lZHUucWE=; Abdel-Naser Elzouki, YWVsem91a2lAaGFtYWQucWE=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.